Global Neurostimulation Devices Market 2019-2029

Price	Length	Publisher	Published Date	SKU
from $4,938	166 Pages	Visiongain	November, 2018	VSG15848118

Price	from $4,938
Length	166 Pages
Publisher	Visiongain
Published Date	November, 2018
SKU	VSG15848118

Global Neurostimulation Devices Market 2019-2029

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 166-page report you will receive 102 charts– all unavailable elsewhere.

The 166-page report provides clear detailed insight into the neurostimulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neurostimulation Devices Market from 2019-2029
Forecast of the Global Neurostimulation Devices market by Product:
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Cortical Stimulators
Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

Forecast of the Global Neurostimulation Devices market by Application:
Pain Management
Epilepsy
Urinary and Fecal Incontinence
Hearing Loss
Gastroparesis
Parkinson’s Disease
Others

This report provides individual revenue forecasts to 2028 for these regional and national markets:
North America: US, Canada
Europe: Germany, France, United Kingdom, Italy, Spain and rest of Europe
Asia-Pacific: Japan, China, India and rest of Asia-Pacific
RoW: Latin America, Middle East & Africa
Our study discusses the selected leading companies that are the major players in the neurostimulation devices market:
Advanced Bionics
Boston Scientific Corporation
Cochlear ltd
Cyberonics
Medtronic
Neuronetics Inc
Nervo Corp.
Cogentic Medical Inc
St Jude Medical
NDI Medical
Our study discusses the factors that drive and restrain the neurostimulation devices market:

Visiongain’s study is intended for anyone requiring commercial analyses for the neurostimulation devices market. You find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.

1. Report Overview: 1.1 Why You Should Read This Report; 1.2 How This Report Delivers; 1.3 Key Questions Answered by This Analytical Report Include:; 1.4 Who is This Report for?; 1.5 Methodology; 1.5.1 Primary Research; 1.5.2 Secondary Research; 1.5.3 Market Evaluation & Forecasting Methodology; 1.6 Frequently Asked Questions (FAQ); 1.7 Associated Visiongain Reports; 1.8 About Visiongain
2. Introduction to the Neurostimulation Devices Market: 2.1 Classification of Neurostimulation Devices; 2.2 What are Neurostimulation Devices?; 2.3 Regulation of Medical Devices?; 2.3.1 The US Approval and Regulation System; 2.3.2 The EU Approval and Regulation System; 2.3.3 China Approval and Regulation System; 2.3.4 Japan Approval and Regulation System; 2.3.5 India Approval and Regulation System
3. Neurostimulation Devices Market: Drivers & Restraints: 3.1 Driving Factors; 3.1.1 Growing prevalence of neurological disorders; 3.1.2 Increasing Growth of Aging Population; 3.1.3 Changing Lifestyle and growing obesity; 3.1.4 Various opportunities from emerging markets; 3.2 Market Restraints; 3.2.1 Shortage of neurologists to treat an increasing number of neurologic patients; 3.2.2 Uncertain outcomes of changing healthcare policies; 3.2.3 Imposition of the medical device excise tax in the U.S.; 3.2.4 Poor primary healthcare infrastructure and lack of healthcare insurance in developing countries
4. Global Neurostimulation Devices Market by Product, 2019-2029: 4.1 Spinal Cord Stimulators Market Forecast 2019-2029; 4.2 Deep Brain Stimulators Market Forecast 2019-2029; 4.3 Vagus Nerve Stimulators Market Forecast 2019-2029; 4.4 Sacral Nerve Stimulators: Market Forecast 2019-2029; 4.5 Cortical Stimulators Market Forecast 2019-2029; 4.6 Other Neurostimulation Devices Market Forecast 2019-2029
5. Global Neurostimulation Devices Market by Application, 2019-2029: 5.1 Epilepsy Neurostimulation Devices Market Forecast 2019-2029; 5.2 Pain Management Neurostimulation Devices Market Forecast 2019-2029; 5.3 Hearing Loss Neurostimulation Devices Market Forecast 2019-2029; 5.4 Urinary and Faecal Incontinence Neurostimulation Devices Market Forecast 2019-2029; 5.5 Gastroparesis Neurostimulation Devices Market Forecast 2019-2029; 5.6 Parkinson’s Disease Neurostimulation Devices Market Forecast 2019-2029; 5.7 Others Application Market Forecast 2019-2029
6. Global Neurostimulation Devices Market by Region, 2019-2029: 6.1 Introduction; 6.2 Regional Breakdown of the Global Neurostimulation Devices Market; 6.3 How will Regional Market Shares Change to 2029?; 6.4 North America Neurostimulation Devices Market 2019-2029; 6.4.1 U.S. Neurostimulation Devices Market Forecast 2019-2029; 6.4.2 Canada Neurostimulation Devices Market Forecast 2019-2029; 6.5 Europe Neurostimulation Devices Market Forecast 2019-2029; 6.5.1 Germany Neurostimulation Devices Market Forecast 2019-2029; 6.5.2 France Neurostimulation Devices Market Forecast 2019-2029; 6.5.3 UK Neurostimulation Devices Market Forecast 2019-2029; 6.5.4 Italy Neurostimulation Devices Market Forecast 2019-2029; 6.5.5 Spain Neurostimulation Devices Market Forecast 2019-2029; 6.5.6 Rest of Europe (RoE); 6.6 Asia-Pacific Neurostimulation Devices Market Forecast 2019-2029; 6.6.1 Japan Neurostimulation Devices Market Forecast 2019-2029; 6.6.2 China Neurostimulation Devices Market Forecast 2019-2029; 6.6.3 India Neurostimulation Devices Market Forecast 2019-2029; 6.6.4 Rest of Asia-pacific Neurostimulation Devices Market Forecast 2019-2029; 6.7 Rest of the World Neurostimulation Devices Market Forecast 2019-2029; 6.7.1 Latin America Neurostimulation Devices Market Forecast 2019-2029; 6.7.2 Middle East & Africa Neurostimulation Devices Market Forecast 2019-2029
7. Leading Companies in the Neurostimulation Devices Market: 7.1 Advanced Bionics, LLC; 7.1.1 Advanced Bionics, LLC: Overview; 7.1.2 Advanced Bionics, LLC: Financials; 7.1.3 Advanced Biologics, LLC: Product Portfolio; 7.1.4 Advanced Biologics, LLC: Developments; 7.2 Boston Scientific Corporation; 7.2.1 Boston Scientific: Overview; 7.2.2 Boston Scientific: Financials; 7.2.3 Boston Scientific: Product portfolio; 7.2.4 Boston Scientific: Developments; 7.3 Cochlear Ltd.; 7.3.1 Cochlear Ltd.: Overview; 7.3.2 Cochlear Ltd.: Financials; 7.3.3 Cochlear Ltd.: Product Portfolio; 7.3.4 Cochlear Ltd.: Developments; 7.4 Cyberonics; 7.4.1 Cyberonics: Overview; 7.4.2 Cyberonics: Financials; 7.4.3 Cyberonics: Products Portfolio; 7.4.4 Cyberonics: Developments; 7.5 Medtronic plc; 7.5.1 Medtronic plc: Overview; 7.5.2 Medtronic plc: Financials; 7.5.3 Medtronic plc: Product Portfolio; 7.5.4 Medtronic plc: Developments; 7.6 Neuronetics, Inc.; 7.6.1 Neuronetics, Inc: Overview; 7.6.2 Neuronetics, Inc: Financials; 7.6.3 Neuronetics, Inc: Product Portfolio; 7.6.4 Developments; 7.7 Nevro Corp.; 7.7.1 Nevro Corp.: Overview; 7.7.2 Nevro Corp.: Financials; 7.7.3 Nevro Corp.: Product Portfolio; 7.7.4 Nevro Corp.: Developments; 7.8 Cogentix Medical Inc; 7.8.1 Cogentix Medical Inc: Overview; 7.8.2 Cogentix Medical Inc: Financials; 7.8.3 Cogentix Medical Inc: Product Portfolio; 7.8.4 Cogentix Medical Inc: Developments; 7.9 St. Jude Medical; 7.9.1 St. Jude Medical: Overview; 7.9.2 St. Jude Medical: Financials; 7.9.3 St. Jude Medical: Product Portfolio; 7.9.4 St. Jude Medical: Developments; 7.10 NDI Medical, LLC.; 7.10.1 NDI Medical, LLC.: Overview; 7.10.2 NDI Medical, LLC.: Product portfolio; 7.10.3 NDI Medical, LLC.: Developments
8. The Global Neurostimulation Devices Market, Competitive Landscape: 8.1 New Product Launches; 8.2 Acquisitions, Collaborations, and Partnerships; 8.3 Other Developments
9. Conclusions: 9.1 Top Neurostimulation Devices Market; 9.2 Top Neurostimulation Devices Applications Market; 9.3 Top Nations Neurostimulation in the Devices Market; Appendices; Associated Visiongain Reports; Visiongain Report Sales Order Form; About Visiongain; Visiongain report evaluation form
List of Tables: Table 4.1 Neurostimulation Devices Submarkets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 4.3 Deep Brain Stimulators by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 4.4 Vagus Nerve Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 4.6 Cortical Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 4.7 Other Neurostimulation devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.1 Neurostimulation devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.5 Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.6 Gastroparesis Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.7 Parkinson’s Disease Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 5.8 Other Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.1 Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.2 North America Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.3 North America Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.4 North America Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.5 Europe Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.6 Europe Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.7 Europe Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.8 Asia-Pacific Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.9 Asia-Pacific Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.10 Asia-Pacific Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.11 Rest of the World Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.12 Rest of the World Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 6.13 Rest of the World Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029; Table 7.1 Advanced Bionics Product Portfolio; Table 7.2 Advanced Bionics: Developments; Table 7.3 Boston Scientific Corporation: Product Portfolio; Table 7.4 Boston Scientific Corporation: Developments; Table 7.5 Cochlear Ltd.: Product Portfolio; Table 7.6 Cochlear Ltd.: Developments; Table 7.7 Cyberonics.: Product Portfolio; Table 7.8 Cyberonics: Developments; Table 7.9 Medtronic plc: Product Portfolio; Table 7.10 Medtronic plc: Developments; Table 7.11 Neuronetics: Product Portfolio; Table 7.12 Neuronetics: Developments; Table 7.13 Nevro Corp: Product Portfolio; Table 7.14 Nevro Corp: Developments; Table 7.15 Cogentix Medical: Product Portfolio; Table 7.16 Cogentix Medical: Developments; Table 7.17 St. Jude Medical: Product Portfolio; Table 7.18 St. Jude Medical: Developments; Table 7.19 NDI Medical: Product Portfolio; Table 7.20 NDI Medical: Developments; Table 8.1 New Product Launches; Table 8.2 Acquisitions, Collaborations, and Partnerships; Table 8.3 Other Developments
List of Figures: Figure 2.1 Neurostimulation Devices Market Segmentation; Figure 2.2 Stages of regulatory control; Figure 3.1 Neurostimulation Devices Market: Drivers and Restraints, 2019-2029; Figure 3.2 Share of geriatric population, by region, 2010-2020; Figure 4.1 Neurostimulation Devices Submarkets by Product: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 4.3 Deep Brain Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 4.4 Vagus Nerve Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m), 2019-2029; Figure 4.6 Cortical Stimulators by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 4.7 Other Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.1 Neurostimulation Devices Markets by Application: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.5 Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.6 Gastroparesis Neurostimulation devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.7 Parkinson’s Disease Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029; Figure 5.8 Other Neurostimulation Devices Markets by Region: Forecast ($m), 2019-2029; Figure 6.1 Neurostimulation Devices Markets by Region: Share (%), 2018; Figure 6.2 North America Neurostimulation Devices Markets by Country: Share (%), 2018; Figure 6.3 U.S. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.4 Increasing Prevalence Rate in Canada by Chronic Diseases, 2001-2039; Figure 6.5 Canada Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.6 Europe Neurostimulation Devices Markets by Country: Share (%), 2018; Figure 6.7 Change in population structure in Germany, 1995-2015; Figure 6.8 Germany Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.9 France Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.10 U.K. Population estimates and projections, 2010-2039; Figure 6.11 U.K. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.12 Italy Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.13 Spain Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.14 Asia-Pacific Neurostimulation Devices Markets by Country (%), 2018; Figure 6.15 Japan Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.16 Share of Aging population in total Chinese population, 2011-2016 (%); Figure 6.17 China Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.18 India Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029; Figure 6.19 Rest of the World Neurostimulation Devices Markets by Region (%), 2018; Figure 6.20 Latin America Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029

Electronic Access - Departmental 1-5 Users Fulfilled By Publisher:	$5,625
Electronic Access - Global Site License Fulfilled By Publisher:	$8,688
Electronic Access - Single User Fulfilled By Publisher:	$4,938
Electronic Access - Site License Fulfilled By Publisher:	$6,875